Refined estimates of local recurrence risks by DCIS score adjusting for clinicopathological features: a combined analysis of ECOG-ACRIN E5194 and Ontario DCIS cohort studies.
Eileen RakovitchR GrayF L BaehnerR SutradharM CragerS GuS Nofech-MozesS S BadveW HannaL L HughesW C WoodN E DavidsonL PaszatS ShakJ A SparanoL J SolinPublished in: Breast cancer research and treatment (2018)
The combined analysis provides refined estimates of 10-year LR risk after BCS for DCIS. Adding information on tumor size and age at diagnosis to the DS adjusting for year of diagnosis provides improved LR risk estimates to guide treatment decision making.